Question 1

What is THROMBIN TOPICAL RECOMBINANT used for?

Accepted Answer

THROMBIN TOPICAL RECOMBINANT (brand name RECOTHROM) is a Topical Agent indicated for 1 INDICATIONS AND USAGE RECOTHROM Thrombin topical (Recombinant), ligature, or cautery) is ineffective or impractical in adults and pediatric populations greater than or equal to one month of age. RECOTHROM may be used in conjunction with an absorbable gelatin sponge.

Question 2

How does THROMBIN TOPICAL RECOMBINANT work?

Accepted Answer

THROMBIN TOPICAL RECOMBINANT works through the following mechanism: 12.1 Mechanism of Action RECOTHROM Thrombin topical (Recombinant), is a specific human serine protease that promotes hemostasis and acts locally when applied topically to a site of bleeding. RECOTHROM activates platelets and catalyzes the conversion of fibrinogen to fibrin, which are steps that are essential for blood clot formation..

Question 3

What are the most common side effects of THROMBIN TOPICAL RECOMBINANT?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for THROMBIN TOPICAL RECOMBINANT. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is THROMBIN TOPICAL RECOMBINANT the same as RECOTHROM?

Accepted Answer

RECOTHROM is a brand name for THROMBIN TOPICAL RECOMBINANT. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

THROMBIN TOPICAL RECOMBINANT

Mechanism of Action

Indications

FDA Warnings

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations